SlideShare a Scribd company logo
GOOD PRACTICES IN
PRODUCTION
Good Practices in Production
Principle :- Production operations must follow clearly
defined procedures in accordance with manufacturing
and marketing authorizations, with the objective of
obtaining products of the requisite quality.
General
1. All handling of materials and products, such as
receipt and cleaning, quarantine, sampling, storage,
labelling, dispensing, processing, packaging and
distribution should be done in accordance with
written procedures or instructions and, where
necessary, recorded.
Contd.
2. Any deviation from instructions or procedures
should be avoided as far as possible. If deviations
occur, they should be done in accordance with an
approved procedure. The authorization of the
deviation should be approved in writing by a
designated person, with the involvement of the QC
department, when appropriate.
3. Checks on yields and reconciliation of quantities
should be carried out as necessary to ensure that
there are no discrepancies outside acceptable limits.
Contd.
4. Operations on different products should not be carried out
simultaneously or consecutively in the same room or area
unless there is no risk of mix up or cross-contamination.
5. At all times during processing, all materials, bulk containers,
major items of equipment, and where appropriate, the rooms
and packaging lines being used should be labelled or
otherwise identified with an indication of the product or
material being processed, its strength (where applicable) and
the batch number. Where applicable, this indication should
also mention the stage of production. In some cases it may be
useful to also record the name of the previous product that
has been processed. (status label)
Contd.
6. Access to production premises should be restricted
to authorized personnel.
7. Normally, non-medicinal products should not be
produced in areas or with equipment destined for the
production of pharmaceutical products.
Prevention of cross-contamination and
bacterial contamination during production
1. When dry materials and products are used in
production, special precautions should be taken to
prevent the generation and dissemination of dust.
2. Provision should be made for proper air control (e.g.
supply and extraction of air of suitable quality).
Contd.
3. Contamination of a starting material or of a product
by another material or product must be avoided.
4. This risk of accidental cross-contamination arises
from the uncontrolled release of dust, gases,
particles, vapours, sprays or organisms from
materials and products in process, from residues on
equipment, from intruding insects, and from
operators’ clothing, skin, etc.
5. The significance of this risk varies with the type of
contaminant and of the product being contaminated.
Contd.
6. Among the most hazardous contaminants are highly
sensitizing materials, biological preparations such as
living organisms, certain hormones, cytotoxic
substances, and other highly active materials.
7. Products in which contamination is likely to be
most significant are those administered by injection
or applied to open wounds and those given in large
doses and/or over a long time.
Contd.
8. Cross-contamination should be avoided by taking
appropriate technical or organizational measures, for
example,
(a) Carrying out production in dedicated and self-
contained areas (which may be required for
products such as penicillins, live vaccines, live
bacterial preparations and certain other biologicals);
(b) Conducting campaign production (separation in time)
followed by appropriate cleaning in accordance with
a validated cleaning procedure;
(c) Providing appropriately designed airlocks, pressure
differentials, and supply and extraction systems.
Contd.
d) Minimizing the risk of contamination caused by
recirculation or re-entry of untreated or
insufficiently treated air;
e) Wearing protective clothing when products or
materials are handled.
f) Using cleaning and decontamination procedures of
known effectiveness.
g) Using a “closed system” in production.
h) Testing for residues.
i) Using cleanliness status labels on equipment
Contd.
9. Measures to prevent cross-contamination and their
effectiveness should be checked periodically
according to SOPs.
10. Production areas where susceptible products are
processed should undergo periodic environmental
monitoring (e.g. for microbiological monitoring and
particulate matter where appropriate).
Processing operations
• Before any processing operation is started, steps
should be taken to ensure that the work area and
equipment are clean and free from any starting
materials, products, product residues, labels or
documents not required for the current operation.
• Any necessary in-process controls and environmental
controls should be carried out and recorded.
Contd.
• Defective equipment should be withdrawn from use
until the defect has been rectified. After use,
production equipment should be cleaned without
delay according to detailed written procedures and
stored under clean and dry conditions in a separate
area or in a manner that will prevent contamination.
Contd.
• Time limits for storage of equipment after cleaning
and before use should be stated.
• Containers for filling should be cleaned before filling.
Attention should be given to avoiding and removing
any contaminants such as glass fragments and metal
particles
• Any significant deviation from the expected yield
should be recorded and investigated.
Contd.
• Checks should be carried out to ensure that pipelines
and other pieces of equipment used for the
transportation of products from one area to another
are connected in a correct manner.
• Pipes used for conveying distilled or de-ionized water
and, where appropriate, other water pipes should be
sanitized and stored according to written procedures.
Contd.
• Measuring, weighing, recording, and control
equipment and instruments should be serviced and
calibrated at pre-specified intervals and records
maintained. To ensure satisfactory functioning,
instruments should be checked daily or prior to use
for performing analytical tests.
• The date of calibration and servicing and the date
when recalibration is due should be clearly indicated
on a label attached to the instrument.
• Repair and maintenance operations should not present
any hazard to the quality of the products
Packaging operations
• When the programme for packaging operations is being
set up, particular attention should be given to minimizing
the risk of cross-contamination, mix-ups or substitutions.
• Different products should not be packaged in close
proximity unless there is physical segregation or an
alternative system that will provide equal assurance.
• Before packaging operations are begun, steps should be
taken to ensure that the work area, packaging lines,
printing machines and other equipment are clean and free
from any products, materials or documents used
previously and which are not required for the current
operation.
• The line clearance should be performed according to an
appropriate procedure and checklist, and recorded.
(Packaging line clearance)
Contd.
• The name and batch number of the product being
handled should be displayed at each packaging station
or line. (status board)
• Normally, filling and sealing should be followed as
quickly as possible by labelling.
• If labelling is delayed, appropriate procedures should
be applied to ensure that no mix ups or mislabelling
can occur.
Contd.
• The correct performance of any printing (e.g. of code
numbers or expiry dates) done separately or in the
course of the packaging should be checked and
recorded. (printing approval)
• Attention should be paid to printing by hand, which
should be rechecked at regular intervals.
• Printed and embossed information on packaging
materials should be distinct and resistant to fading or
erasing.
Contd.
• Regular online control of the product during
packaging should include at least checks on.
(a) The general appearance of the packages
(b) Whether the packages are complete
(c) Whether the correct products and packaging
materials are used
(d) Whether any overprinting is correct
(e) The correct functioning of line monitors
(Samples taken away from the packaging line should
not be returned.)
Contd.
• Products that have been involved in an unusual event
during packaging should be reintroduced into the process
only after special inspection, investigation and approval
by authorized personnel. (A detailed record should be
kept of this operation.)
(Previous Batch recovery at packaging stage)
• Any significant or unusual discrepancy observed during
reconciliation of the amount of bulk product and printed
packaging materials and the number of units produced
should be investigated, satisfactorily accounted for, and
recorded before release.
Contd.
• Upon completion of a packaging operation, any unused
batch-coded packaging materials should be destroyed and
the destruction recorded.
• A documented procedure requiring checks to be
performed before returning unused materials should be
followed if un-coded printed materials are returned to
stock.
• Production records should be reviewed as part of the
approval process of batch release before transfer to the
authorized person.
• Any divergence or failure of a batch to meet production
specifications should be thoroughly investigated.
Contd.
• The investigation should, if necessary, extend to other
batches of the same product and other products that
may have been associated with the specific failure or
discrepancy.
• A written record of the investigation should be made
and should include the conclusion and follow up
action.

More Related Content

What's hot

Documentation...
Documentation...Documentation...
Documentation...
ABIYA SARA CHERIAN
 
Documentation in Pharmaceutical Industry Part I
Documentation in Pharmaceutical Industry Part I Documentation in Pharmaceutical Industry Part I
Documentation in Pharmaceutical Industry Part I
Tarif Hussian
 
Mfr
MfrMfr
Pharmaceutical Documentation
Pharmaceutical DocumentationPharmaceutical Documentation
Pharmaceutical Documentation
Teny Thomas
 
MFR
MFRMFR
Master batch record,batch production record ,Quality Audit Type and plan &Rec...
Master batch record,batch production record ,Quality Audit Type and plan &Rec...Master batch record,batch production record ,Quality Audit Type and plan &Rec...
Master batch record,batch production record ,Quality Audit Type and plan &Rec...
KarishmaFuse
 
Manufacturing Documentation
Manufacturing DocumentationManufacturing Documentation
Manufacturing Documentation
Sagar Savale
 
Review of Quality Control Record and Analytical Data by Dr. A. Amsavel
Review of  Quality Control Record and Analytical Data by Dr. A. AmsavelReview of  Quality Control Record and Analytical Data by Dr. A. Amsavel
Review of Quality Control Record and Analytical Data by Dr. A. Amsavel
Dr. Amsavel A
 
C gmp and industrial management
C gmp and industrial managementC gmp and industrial management
C gmp and industrial management
PradipkumarRathod1
 
2.basics of good mfg practice (gmp)
2.basics of good mfg practice (gmp)2.basics of good mfg practice (gmp)
2.basics of good mfg practice (gmp)
William Dube
 
cGMP AS PER USFDA
cGMP AS PER USFDAcGMP AS PER USFDA
Six system inspection model
Six system inspection modelSix system inspection model
Six system inspection model
DhrutiPatel61
 
Review of-batch-production-records
Review of-batch-production-recordsReview of-batch-production-records
Review of-batch-production-records
Dr. Ray Ziai
 
Master formula record
Master formula recordMaster formula record
Master formula record
Doninder Hooda
 
Documentation in pharmaceutical industry
Documentation in pharmaceutical industryDocumentation in pharmaceutical industry
Documentation in pharmaceutical industry
GayatriTiwaskar
 
Current good manufacturing practice
Current good manufacturing practiceCurrent good manufacturing practice
Current good manufacturing practice
Dr Subodh Satheesh
 
2 the regulations
2 the regulations2 the regulations
2 the regulations
Shirley Roach
 
GMP Training: Handling of deviation
GMP Training: Handling of deviationGMP Training: Handling of deviation
GMP Training: Handling of deviation
Dr. Amsavel A
 
Quality Review
Quality ReviewQuality Review
Quality Review
AJAYKUMAR4872
 
Handling of Reserve Samples Dr.A. Amsavel
Handling of Reserve Samples Dr.A. AmsavelHandling of Reserve Samples Dr.A. Amsavel
Handling of Reserve Samples Dr.A. Amsavel
Dr. Amsavel A
 

What's hot (20)

Documentation...
Documentation...Documentation...
Documentation...
 
Documentation in Pharmaceutical Industry Part I
Documentation in Pharmaceutical Industry Part I Documentation in Pharmaceutical Industry Part I
Documentation in Pharmaceutical Industry Part I
 
Mfr
MfrMfr
Mfr
 
Pharmaceutical Documentation
Pharmaceutical DocumentationPharmaceutical Documentation
Pharmaceutical Documentation
 
MFR
MFRMFR
MFR
 
Master batch record,batch production record ,Quality Audit Type and plan &Rec...
Master batch record,batch production record ,Quality Audit Type and plan &Rec...Master batch record,batch production record ,Quality Audit Type and plan &Rec...
Master batch record,batch production record ,Quality Audit Type and plan &Rec...
 
Manufacturing Documentation
Manufacturing DocumentationManufacturing Documentation
Manufacturing Documentation
 
Review of Quality Control Record and Analytical Data by Dr. A. Amsavel
Review of  Quality Control Record and Analytical Data by Dr. A. AmsavelReview of  Quality Control Record and Analytical Data by Dr. A. Amsavel
Review of Quality Control Record and Analytical Data by Dr. A. Amsavel
 
C gmp and industrial management
C gmp and industrial managementC gmp and industrial management
C gmp and industrial management
 
2.basics of good mfg practice (gmp)
2.basics of good mfg practice (gmp)2.basics of good mfg practice (gmp)
2.basics of good mfg practice (gmp)
 
cGMP AS PER USFDA
cGMP AS PER USFDAcGMP AS PER USFDA
cGMP AS PER USFDA
 
Six system inspection model
Six system inspection modelSix system inspection model
Six system inspection model
 
Review of-batch-production-records
Review of-batch-production-recordsReview of-batch-production-records
Review of-batch-production-records
 
Master formula record
Master formula recordMaster formula record
Master formula record
 
Documentation in pharmaceutical industry
Documentation in pharmaceutical industryDocumentation in pharmaceutical industry
Documentation in pharmaceutical industry
 
Current good manufacturing practice
Current good manufacturing practiceCurrent good manufacturing practice
Current good manufacturing practice
 
2 the regulations
2 the regulations2 the regulations
2 the regulations
 
GMP Training: Handling of deviation
GMP Training: Handling of deviationGMP Training: Handling of deviation
GMP Training: Handling of deviation
 
Quality Review
Quality ReviewQuality Review
Quality Review
 
Handling of Reserve Samples Dr.A. Amsavel
Handling of Reserve Samples Dr.A. AmsavelHandling of Reserve Samples Dr.A. Amsavel
Handling of Reserve Samples Dr.A. Amsavel
 

Similar to Good practice in production

Production in quality assurance
Production  in quality assuranceProduction  in quality assurance
Production in quality assurance
kalai vani
 
Manufacturing operations and Control
Manufacturing operations and ControlManufacturing operations and Control
Manufacturing operations and Control
Shivani Chaudhari
 
GMP presentation.pptx
GMP presentation.pptxGMP presentation.pptx
GMP presentation.pptx
garima mailk
 
cGMP Guidelines according to USFDA
cGMP Guidelines according to USFDAcGMP Guidelines according to USFDA
cGMP Guidelines according to USFDA
MANIKANDAN V
 
PRPs Training.ppt
PRPs Training.pptPRPs Training.ppt
PRPs Training.ppt
JohnNcube2
 
Good manufacturing
Good manufacturingGood manufacturing
Good manufacturing
Dr. Vir Vikram
 
GMP, Goods manufacturer Practices, Drug and Cosmetic act
GMP, Goods manufacturer Practices, Drug and Cosmetic actGMP, Goods manufacturer Practices, Drug and Cosmetic act
GMP, Goods manufacturer Practices, Drug and Cosmetic act
DrSampuranSuahg
 
Manufacturing operation and controls
Manufacturing operation and controls Manufacturing operation and controls
Manufacturing operation and controls
sachin pawar
 
Rekling10 gmp
Rekling10 gmpRekling10 gmp
Rekling10 gmp
Arif Rahman
 
Manufacturing operation and control
Manufacturing operation and controlManufacturing operation and control
Manufacturing operation and control
Malay Pandya
 
Manufacturing operations and controls.pptx
Manufacturing operations and controls.pptxManufacturing operations and controls.pptx
Manufacturing operations and controls.pptx
saurabh11102000
 
GOOD WAREHOUSING PRACTICE.pptx
GOOD WAREHOUSING PRACTICE.pptxGOOD WAREHOUSING PRACTICE.pptx
GOOD WAREHOUSING PRACTICE.pptx
Rohit772019
 
Neutraceuticals GMP
Neutraceuticals GMPNeutraceuticals GMP
Neutraceuticals GMP
SanthiNori1
 
Good warehouse practice
Good warehouse practiceGood warehouse practice
Good warehouse practice
Shivam Rakesh Shinde BVCPK
 
PHARMACEUTICAL PRODUCTION MANAGEMENT & INVENTORY CONTROL
PHARMACEUTICAL PRODUCTION MANAGEMENT & INVENTORY CONTROLPHARMACEUTICAL PRODUCTION MANAGEMENT & INVENTORY CONTROL
PHARMACEUTICAL PRODUCTION MANAGEMENT & INVENTORY CONTROL
Arunpandiyan59
 
GMP of ASU Drugs
GMP of ASU DrugsGMP of ASU Drugs
GMP of ASU Drugs
Akhtar Ali
 
Ketindan 25 april 2013
Ketindan 25 april 2013Ketindan 25 april 2013
Ketindan 25 april 2013
Bbpp Ketindan
 
National gmp 2072
National gmp 2072National gmp 2072
National gmp 2072
sobit poudel
 
warehousing[1]
 warehousing[1] warehousing[1]
warehousing[1]
Himani Chauhan
 
Good practices in production
Good practices in productionGood practices in production
Good practices in production
Md. Shariful Islam
 

Similar to Good practice in production (20)

Production in quality assurance
Production  in quality assuranceProduction  in quality assurance
Production in quality assurance
 
Manufacturing operations and Control
Manufacturing operations and ControlManufacturing operations and Control
Manufacturing operations and Control
 
GMP presentation.pptx
GMP presentation.pptxGMP presentation.pptx
GMP presentation.pptx
 
cGMP Guidelines according to USFDA
cGMP Guidelines according to USFDAcGMP Guidelines according to USFDA
cGMP Guidelines according to USFDA
 
PRPs Training.ppt
PRPs Training.pptPRPs Training.ppt
PRPs Training.ppt
 
Good manufacturing
Good manufacturingGood manufacturing
Good manufacturing
 
GMP, Goods manufacturer Practices, Drug and Cosmetic act
GMP, Goods manufacturer Practices, Drug and Cosmetic actGMP, Goods manufacturer Practices, Drug and Cosmetic act
GMP, Goods manufacturer Practices, Drug and Cosmetic act
 
Manufacturing operation and controls
Manufacturing operation and controls Manufacturing operation and controls
Manufacturing operation and controls
 
Rekling10 gmp
Rekling10 gmpRekling10 gmp
Rekling10 gmp
 
Manufacturing operation and control
Manufacturing operation and controlManufacturing operation and control
Manufacturing operation and control
 
Manufacturing operations and controls.pptx
Manufacturing operations and controls.pptxManufacturing operations and controls.pptx
Manufacturing operations and controls.pptx
 
GOOD WAREHOUSING PRACTICE.pptx
GOOD WAREHOUSING PRACTICE.pptxGOOD WAREHOUSING PRACTICE.pptx
GOOD WAREHOUSING PRACTICE.pptx
 
Neutraceuticals GMP
Neutraceuticals GMPNeutraceuticals GMP
Neutraceuticals GMP
 
Good warehouse practice
Good warehouse practiceGood warehouse practice
Good warehouse practice
 
PHARMACEUTICAL PRODUCTION MANAGEMENT & INVENTORY CONTROL
PHARMACEUTICAL PRODUCTION MANAGEMENT & INVENTORY CONTROLPHARMACEUTICAL PRODUCTION MANAGEMENT & INVENTORY CONTROL
PHARMACEUTICAL PRODUCTION MANAGEMENT & INVENTORY CONTROL
 
GMP of ASU Drugs
GMP of ASU DrugsGMP of ASU Drugs
GMP of ASU Drugs
 
Ketindan 25 april 2013
Ketindan 25 april 2013Ketindan 25 april 2013
Ketindan 25 april 2013
 
National gmp 2072
National gmp 2072National gmp 2072
National gmp 2072
 
warehousing[1]
 warehousing[1] warehousing[1]
warehousing[1]
 
Good practices in production
Good practices in productionGood practices in production
Good practices in production
 

Recently uploaded

District Residency Programme (DRP) for PGs in India.pptx
District Residency Programme (DRP) for PGs in India.pptxDistrict Residency Programme (DRP) for PGs in India.pptx
District Residency Programme (DRP) for PGs in India.pptx
CommunityMedicine46
 
PGx Analysis in VarSeq: A User’s Perspective
PGx Analysis in VarSeq: A User’s PerspectivePGx Analysis in VarSeq: A User’s Perspective
PGx Analysis in VarSeq: A User’s Perspective
Golden Helix
 
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
ayushrajshrivastava7
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
Gokuldas Hospital
 
Introduction to British pharmacopeia.pptx
Introduction to British pharmacopeia.pptxIntroduction to British pharmacopeia.pptx
Introduction to British pharmacopeia.pptx
taiba qazi
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
13. PROM premature rupture of membranes
13.  PROM premature rupture of membranes13.  PROM premature rupture of membranes
13. PROM premature rupture of membranes
TigistuMelak
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Kunj Vihari
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
SIVAVINAYAKPK
 
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
Nutritional deficiency disorder in Child
Nutritional deficiency disorder in ChildNutritional deficiency disorder in Child
Nutritional deficiency disorder in Child
Bhavyakelawadiya
 
biomechanics of running. Dr.dhwani.pptx
biomechanics of running.   Dr.dhwani.pptxbiomechanics of running.   Dr.dhwani.pptx
biomechanics of running. Dr.dhwani.pptx
Dr. Dhwani kawedia
 
RESPIRATORY DISEASES by bhavya kelavadiya
RESPIRATORY DISEASES by bhavya kelavadiyaRESPIRATORY DISEASES by bhavya kelavadiya
RESPIRATORY DISEASES by bhavya kelavadiya
Bhavyakelawadiya
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
pharmacy exam preparation for undergradute students.pptx
pharmacy exam preparation for undergradute students.pptxpharmacy exam preparation for undergradute students.pptx
pharmacy exam preparation for undergradute students.pptx
AdugnaWari
 
Foundation of Yoga, YCB Level-3, Unit-1
Foundation of Yoga, YCB Level-3, Unit-1 Foundation of Yoga, YCB Level-3, Unit-1
Foundation of Yoga, YCB Level-3, Unit-1
Jyoti Bhaghasra
 
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
Gokuldas Hospital
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 

Recently uploaded (20)

District Residency Programme (DRP) for PGs in India.pptx
District Residency Programme (DRP) for PGs in India.pptxDistrict Residency Programme (DRP) for PGs in India.pptx
District Residency Programme (DRP) for PGs in India.pptx
 
PGx Analysis in VarSeq: A User’s Perspective
PGx Analysis in VarSeq: A User’s PerspectivePGx Analysis in VarSeq: A User’s Perspective
PGx Analysis in VarSeq: A User’s Perspective
 
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
 
Introduction to British pharmacopeia.pptx
Introduction to British pharmacopeia.pptxIntroduction to British pharmacopeia.pptx
Introduction to British pharmacopeia.pptx
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
13. PROM premature rupture of membranes
13.  PROM premature rupture of membranes13.  PROM premature rupture of membranes
13. PROM premature rupture of membranes
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
 
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
Nutritional deficiency disorder in Child
Nutritional deficiency disorder in ChildNutritional deficiency disorder in Child
Nutritional deficiency disorder in Child
 
biomechanics of running. Dr.dhwani.pptx
biomechanics of running.   Dr.dhwani.pptxbiomechanics of running.   Dr.dhwani.pptx
biomechanics of running. Dr.dhwani.pptx
 
RESPIRATORY DISEASES by bhavya kelavadiya
RESPIRATORY DISEASES by bhavya kelavadiyaRESPIRATORY DISEASES by bhavya kelavadiya
RESPIRATORY DISEASES by bhavya kelavadiya
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
pharmacy exam preparation for undergradute students.pptx
pharmacy exam preparation for undergradute students.pptxpharmacy exam preparation for undergradute students.pptx
pharmacy exam preparation for undergradute students.pptx
 
Foundation of Yoga, YCB Level-3, Unit-1
Foundation of Yoga, YCB Level-3, Unit-1 Foundation of Yoga, YCB Level-3, Unit-1
Foundation of Yoga, YCB Level-3, Unit-1
 
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 

Good practice in production

  • 2.
  • 3. Good Practices in Production Principle :- Production operations must follow clearly defined procedures in accordance with manufacturing and marketing authorizations, with the objective of obtaining products of the requisite quality. General 1. All handling of materials and products, such as receipt and cleaning, quarantine, sampling, storage, labelling, dispensing, processing, packaging and distribution should be done in accordance with written procedures or instructions and, where necessary, recorded.
  • 4. Contd. 2. Any deviation from instructions or procedures should be avoided as far as possible. If deviations occur, they should be done in accordance with an approved procedure. The authorization of the deviation should be approved in writing by a designated person, with the involvement of the QC department, when appropriate. 3. Checks on yields and reconciliation of quantities should be carried out as necessary to ensure that there are no discrepancies outside acceptable limits.
  • 5. Contd. 4. Operations on different products should not be carried out simultaneously or consecutively in the same room or area unless there is no risk of mix up or cross-contamination. 5. At all times during processing, all materials, bulk containers, major items of equipment, and where appropriate, the rooms and packaging lines being used should be labelled or otherwise identified with an indication of the product or material being processed, its strength (where applicable) and the batch number. Where applicable, this indication should also mention the stage of production. In some cases it may be useful to also record the name of the previous product that has been processed. (status label)
  • 6. Contd. 6. Access to production premises should be restricted to authorized personnel. 7. Normally, non-medicinal products should not be produced in areas or with equipment destined for the production of pharmaceutical products.
  • 7. Prevention of cross-contamination and bacterial contamination during production 1. When dry materials and products are used in production, special precautions should be taken to prevent the generation and dissemination of dust. 2. Provision should be made for proper air control (e.g. supply and extraction of air of suitable quality).
  • 8. Contd. 3. Contamination of a starting material or of a product by another material or product must be avoided. 4. This risk of accidental cross-contamination arises from the uncontrolled release of dust, gases, particles, vapours, sprays or organisms from materials and products in process, from residues on equipment, from intruding insects, and from operators’ clothing, skin, etc. 5. The significance of this risk varies with the type of contaminant and of the product being contaminated.
  • 9. Contd. 6. Among the most hazardous contaminants are highly sensitizing materials, biological preparations such as living organisms, certain hormones, cytotoxic substances, and other highly active materials. 7. Products in which contamination is likely to be most significant are those administered by injection or applied to open wounds and those given in large doses and/or over a long time.
  • 10. Contd. 8. Cross-contamination should be avoided by taking appropriate technical or organizational measures, for example, (a) Carrying out production in dedicated and self- contained areas (which may be required for products such as penicillins, live vaccines, live bacterial preparations and certain other biologicals); (b) Conducting campaign production (separation in time) followed by appropriate cleaning in accordance with a validated cleaning procedure; (c) Providing appropriately designed airlocks, pressure differentials, and supply and extraction systems.
  • 11. Contd. d) Minimizing the risk of contamination caused by recirculation or re-entry of untreated or insufficiently treated air; e) Wearing protective clothing when products or materials are handled. f) Using cleaning and decontamination procedures of known effectiveness. g) Using a “closed system” in production. h) Testing for residues. i) Using cleanliness status labels on equipment
  • 12. Contd. 9. Measures to prevent cross-contamination and their effectiveness should be checked periodically according to SOPs. 10. Production areas where susceptible products are processed should undergo periodic environmental monitoring (e.g. for microbiological monitoring and particulate matter where appropriate).
  • 13. Processing operations • Before any processing operation is started, steps should be taken to ensure that the work area and equipment are clean and free from any starting materials, products, product residues, labels or documents not required for the current operation. • Any necessary in-process controls and environmental controls should be carried out and recorded.
  • 14. Contd. • Defective equipment should be withdrawn from use until the defect has been rectified. After use, production equipment should be cleaned without delay according to detailed written procedures and stored under clean and dry conditions in a separate area or in a manner that will prevent contamination.
  • 15. Contd. • Time limits for storage of equipment after cleaning and before use should be stated. • Containers for filling should be cleaned before filling. Attention should be given to avoiding and removing any contaminants such as glass fragments and metal particles • Any significant deviation from the expected yield should be recorded and investigated.
  • 16. Contd. • Checks should be carried out to ensure that pipelines and other pieces of equipment used for the transportation of products from one area to another are connected in a correct manner. • Pipes used for conveying distilled or de-ionized water and, where appropriate, other water pipes should be sanitized and stored according to written procedures.
  • 17. Contd. • Measuring, weighing, recording, and control equipment and instruments should be serviced and calibrated at pre-specified intervals and records maintained. To ensure satisfactory functioning, instruments should be checked daily or prior to use for performing analytical tests. • The date of calibration and servicing and the date when recalibration is due should be clearly indicated on a label attached to the instrument. • Repair and maintenance operations should not present any hazard to the quality of the products
  • 18. Packaging operations • When the programme for packaging operations is being set up, particular attention should be given to minimizing the risk of cross-contamination, mix-ups or substitutions. • Different products should not be packaged in close proximity unless there is physical segregation or an alternative system that will provide equal assurance. • Before packaging operations are begun, steps should be taken to ensure that the work area, packaging lines, printing machines and other equipment are clean and free from any products, materials or documents used previously and which are not required for the current operation. • The line clearance should be performed according to an appropriate procedure and checklist, and recorded. (Packaging line clearance)
  • 19. Contd. • The name and batch number of the product being handled should be displayed at each packaging station or line. (status board) • Normally, filling and sealing should be followed as quickly as possible by labelling. • If labelling is delayed, appropriate procedures should be applied to ensure that no mix ups or mislabelling can occur.
  • 20. Contd. • The correct performance of any printing (e.g. of code numbers or expiry dates) done separately or in the course of the packaging should be checked and recorded. (printing approval) • Attention should be paid to printing by hand, which should be rechecked at regular intervals. • Printed and embossed information on packaging materials should be distinct and resistant to fading or erasing.
  • 21. Contd. • Regular online control of the product during packaging should include at least checks on. (a) The general appearance of the packages (b) Whether the packages are complete (c) Whether the correct products and packaging materials are used (d) Whether any overprinting is correct (e) The correct functioning of line monitors (Samples taken away from the packaging line should not be returned.)
  • 22. Contd. • Products that have been involved in an unusual event during packaging should be reintroduced into the process only after special inspection, investigation and approval by authorized personnel. (A detailed record should be kept of this operation.) (Previous Batch recovery at packaging stage) • Any significant or unusual discrepancy observed during reconciliation of the amount of bulk product and printed packaging materials and the number of units produced should be investigated, satisfactorily accounted for, and recorded before release.
  • 23. Contd. • Upon completion of a packaging operation, any unused batch-coded packaging materials should be destroyed and the destruction recorded. • A documented procedure requiring checks to be performed before returning unused materials should be followed if un-coded printed materials are returned to stock. • Production records should be reviewed as part of the approval process of batch release before transfer to the authorized person. • Any divergence or failure of a batch to meet production specifications should be thoroughly investigated.
  • 24. Contd. • The investigation should, if necessary, extend to other batches of the same product and other products that may have been associated with the specific failure or discrepancy. • A written record of the investigation should be made and should include the conclusion and follow up action.